TRAF3 and neoplasm: Our analysis of the PELI1-TRAF3 axis in Th17 cell-driven anti-tumor immunity revealed that Traf3-cKO in Th17 cells promoted tumor growth (Fig. 3A–D), worsened prognosis (Fig. 3E), and reduced Th17 cell infiltration (Fig. 3F).